Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Oct;107(2):273-5.
doi: 10.1111/j.1476-5381.1992.tb12737.x.

Non-specific activity of (+/-)-CP-96,345 in models of pain and inflammation

A Nagahisa  1 , R Asai, Y Kanai, A Murase, M Tsuchiya-Nakagaki, T Nakagaki, T C Shieh, K Taniguchi
Affiliations

Non-specific activity of (+/-)-CP-96,345 in models of pain and inflammation

A Nagahisa et al. Br J Pharmacol. 1992 Oct.

Abstract

The non-peptide NK1 receptor antagonist, CP-96,345, and its 2R,3R enantiomer CP-96,344, which is not an NK1 receptor antagonist (IC50 > 10 microM), were evaluated for antinociceptive and anti-inflammatory activities in several classical models of pain and inflammation in the rat. Both CP-96,345 and CP-96,344 reduced carrageenin-induced paw oedema and hyperalgesia, and attenuated the second phase of formalin-induced paw licking with equal potency. These results indicate that NK1 antagonism is not responsible for the activity of (+/-)-CP-96,345 in the above animal models.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Br J Pharmacol. 1992 Mar;105(3):508-10 - PubMed
    1. Eur J Pharmacol. 1992 Jul 7;217(2-3):191-5 - PubMed
    1. J Med Chem. 1992 Jul 10;35(14):2591-600 - PubMed
    1. Science. 1991 Jan 25;251(4992):435-7 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1991 Oct;344(4):471-7 - PubMed